Teva Pharmaceutical Q4 2023 Earnings Results

Teva Pharmaceutical Industries reported fourth quarter and full year 2023 financial results, discussing its Pivot to Growth strategy focused on expanding innovative medicines and biosimilar portfolios while managing generic product dependencies. The presentation outlines operational challenges including supply chain disruptions, geopolitical impacts, and regulatory compliance matters.